Showing 34,862 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Bone & joint problems

Alcohol, Smoking, Drugs, Liver Disease-But Not TDF-Predict Fracture With HIV

Editor's pick
NATAP
11 August 2022
Coronavirus

Major Update to the COVID-19 Treatment Guidelines

Editor's pick
HIV.gov
11 August 2022
Sexually transmitted infections prevention

AIDS 2022: What does an important STI prevention finding mean for South Africa?

Editor's pick
Spotlight
11 August 2022
HIV & criminal law

Decriminalizing HIV: Scientifically proven and morally correct

Editor's pick
STAT
11 August 2022
Mpox (monkeypox)

CDC’s Daskalakis on Monkeypox, Stigma, and being ‘the Gay in the Room’

Editor's pick
My Fabulous Disease
11 August 2022
Opportunistic infections

Cytomegalovirus Viremia Increases Mortality Risk in HIV-Associated Meningitis

Editor's pick
Infectious Disease Advisor
11 August 2022
Mpox (monkeypox)

Monkeypox vaccine maker voices concerns on U.S. dose-splitting plan

Editor's pick
Washington Post
11 August 2022
Transgender people

Injectable PrEP is just as effective for transgender women as it is for gay men, study analysis finds

News
11 August 2022
Combatting stigma

What works to reduce HIV stigma?

Editor's pick
Be In The Know
10 August 2022
Access to healthcare

HIV patients in India protest shortage of drugs

Editor's pick
Deutsche Welle
10 August 2022
Mpox (monkeypox)

CDC: People with Untreated or Advanced HIV May be at Risk for Severe Monkeypox

Editor's pick
Contagion Live
10 August 2022
Injectable & long-acting HIV treatment

Long-Acting Injectable HIV Therapy for People Who Won’t Take ART?

Editor's pick
NEJM Journal Watch
10 August 2022
Mpox (monkeypox)

Anger and anxiety stalk EU’s monkeypox vaccine lottery

Editor's pick
POLITICO
10 August 2022
Injectable & long-acting PrEP

Preventive HIV drug shows urgent need for transparency on pricing

Editor's pick
Nature (editorial)
10 August 2022
Access to healthcare

Texas lawsuit aims to gut birth control and HIV medication coverage from health insurance plans

Editor's pick
The Hill
10 August 2022

AIDS 2022: Cabotegravir e rilpivirina injetáveis de ação prolongada podem ser autoadministrados? Terça-feira, 9 de agosto de 2022

August 2022

AIDS 2022: Cabotegravir e rilpivirina in formulazione iniettabile a lunga durata d’azione: sarà possibile l’autosomministrazione? Martedì 9 agosto 2022

August 2022

AIDS 2022: ¿Podría autoadministrarse la formulación inyectable de acción prolongada de cabotegravir y rilpivirina? Martes, 9 de agosto de 2022

August 2022

AIDS 2022 : Peut-on s'injecter soi-même le cabotégravir et la rilpivirine injectables à action prolongée ?, Mardi 9 aout 2022

August 2022
Treatment outcomes & life expectancy

Immune Recovery, Integrase Inhibitors Improve Survival for People With Late HIV Diagnosis

Editor's pick
POZ
9 August 2022

СПИД 2022: Будет ли возможно самостоятельно вводить инъекции пролонгированных каботегравир и рилпивирин? Вторник, 9 августа 2022 г.

August 2022
Child developmental issues

Differences in Early Growth Small for ART-Conceived Infants

Editor's pick
HealthDay News
9 August 2022
Injectable & long-acting HIV treatment

New formulations and alternative injection sites might allow self-administration of long-acting cabotegravir and rilpivirine

News
9 August 2022
Migrants, refugees & displaced people

Early response to Ukrainian refugees enabled continuity of HIV care, but longer-term issues must be addressed as war drags on

News
9 August 2022